[O26-3] O26-3: Pharmacogenomics (1)

[O26-3-4] Dihydropyrimidine dehydrogenase deficiency in patients treated with 5FU or capecitabine based regimens: a tertiary care centre experience

Pavithran Keechilat¹, Arun Philip², Akhila Sivadas³, Judith Mary Hariprakash⁴, Aradhana A.⁵, Akhilesh Kumar Sonakar⁶, Vinod Scaria⁷ (1.Amrita Insitute of Medical Sciences, 2.Amrita Insitute of Medical Sciences, 3.Amrita Insitute of Medical Sciences, 4.CSIR Institute of Genomics and Integrative Biology, 5.CSIR Institute of Genomics and Integrative Biology, 6.CSIR Institute of Genomics and Integrative Biology, 7.CSIR Institute of Genomics and Integrative Biology)

キーワード：Dihydropyrimidine dehydrogenase deficiency 5FU, Capecitabine, Toxicity,